E A Sausville

Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity.

E. Sausville, M. Stetler-Stevenson, O. Sartor, 1993, Biochemical pharmacology.

PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

R. Burger, E. Sausville, R. Coleman, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SJG-136 (NSC 694501), a Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity

E. Sausville, P. McHugh, L. Kèlland, 2004, Cancer Research.

Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles

E. Sausville, G. Yu, W. Rice, 1996, Journal of virology.

Antiproliferative activity in vitro and in vivo of the spicamycin analogue KRN5500 with altered glycoprotein expression in vitro.

E. Sausville, M. Hollingshead, G. Kaur, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.